A Real-world Experience With Tezepelumab as the First Biologic Option in Severe Asthma Patients

被引：0
|
作者：
Mohan, A. [1 ]
Bagheri, A. [1 ]
Senn, R. [1 ]
Harwood, H. [1 ]
Fergan, J. [1 ]
Derstine, B. [2 ]
Lugogo, N. L. [1 ]
机构：
[1] Univ Michigan, Pulm & Crit Care Med, Ann Arbor, MI USA
[2] Univ Michigan, Dept Surg, Morph Anal Grp, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5392
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TEZEPELUMAB IS EFFECTIVE IN REDUCING EXACERBATIONS AFTER BIOLOGIC SWITCHING: REAL-WORLD EXPERIENCE IN A COHORT OF IN SEVERE ASTHMA PATIENTS
    Bagheri, Amirbehzad
    Senn, Rebecca
    Harwood, Hannah
    Derstine, Brian
    Mohan, Arjun
    Lugogo, Njira L.
    CHEST, 2023, 164 (04) : 63A - 66A
  • [2] The Real-world Effectiveness of Tezepelumab in a Cohort of Patients with Severe Asthma
    Nopsopon, Tanawin
    Brown, Alyson
    Akenroye, Ayobami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB96 - AB96
  • [3] Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany
    Biener, Leonie
    Muemmler, Carlo
    Hinze, Christopher Alexander
    Suhling, Hendrik
    Korn, Stephanie
    Fisser, Christoph
    Biener, Arne
    Pizarro, Carmen
    Lenoir, Alexandra
    Hackl, Caroline
    Skowasch, Dirk
    Milger, Katrin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (09):
  • [4] Real-world Experience With Tezepelumab for Severe Asthma in an Academic Medical Center
    Crowther, L.
    Strome, S.
    Akuthota, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] A Real-world Experience on New Starts Versus Biological Switchers for Tezepelumab in Severe Asthma
    Mohan, A.
    Senn, R.
    Harwood, H.
    Derstine, B.
    Fergan, J.
    Bagheri, A.
    Lugogo, N. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [6] First Real-Life Experience with Tezepelumab in Adolescents with severe Asthma
    Trischler, J.
    Scheele, D.
    Schulze, J.
    Bluemchen, K.
    KLINISCHE PADIATRIE, 2024, 236 (02): : S5 - S5
  • [7] Benralizumab effectiveness in patients with severe asthma regardless of prior biologic use: A real-world Canadian experience
    Nair, Parameswaran
    Kayaniyil, Sheena
    St Pierre, Charles
    Osenenko, Katherine
    Li, Tina
    Johnston, Karissa
    Lacuesta, Gina
    Khan, Irfan
    Anees, Syed
    Lai, Yew Hon
    Rahimi, Parisa
    Dhawan, Vivek
    Dorscheid, Delbert
    Cote, Andreanne
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study
    Albers, Frank C.
    Muellerova, Hana
    Gunsoy, Necdet B.
    Shin, Ji-Yeon
    Nelsen, Linda M.
    Bradford, Eric S.
    Cockle, Sarah M.
    Suruki, Robert Y.
    JOURNAL OF ASTHMA, 2018, 55 (02) : 152 - 160
  • [9] Asthma control in severe asthma patients treated with tezepelumab: A prospective, observational, real-world evidence study in Europe and Canada (ASCENT)
    Milger-Kneidinger, Katrin
    Del Dorscheid
    Gessner, Christian
    Sundbom, Fredrik
    Stolz, Daiana
    Urbanski, Hannah
    Le, Tham
    Emmanuel, Benjamin
    Tran, Trung
    Clarke, Deborah
    Llanos, Jean-Pierre
    Clarke, Nicole
    Ruckh, Tim
    Kayaniyil, Sheena
    Martin, Neil
    Stjepanovic, Neda
    Porsbjerg, Celeste
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
    Menzella, Francesco
    Bonavia, Marco
    Bonini, Matteo
    D'Amato, Maria
    Lombardo, Salvatore
    Murgia, Nicola
    Patella, Vincenzo
    Triggiani, Massimo
    Pelaia, Girolamo
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 149 - 161
12345